CD44 ICD can also interact with CREB to bind to the gene promoter region of PFKFB4, a key enzyme of glycolysis, to regulate the transcription and expression of PFKFB4, thereby regulating breast cancer cell stemness and affecting breast cancer patient prognosis [16]. This evidence concerns the gene PFKFB4 and breast carcinoma.